newsfilter
← Latest News
Business Wire·

Dyax Corp. Appoints Dr. Abbie Celniker to Board of Directors

BURLINGTON, Mass.--(BUSINESS WIRE)--Dyax Corp. (NASDAQ: DYAX), a biopharmaceutical company focused on the development and commercialization of novel biotherapeutics for unmet medical needs, today announced the appointment of Abbie Celniker, Ph.D., to its Board of Directors.